tiprankstipranks
Todos Medical Ltd. (TOMDF)
OTHER OTC:TOMDF
US Market

Todos Medical (TOMDF) Stock Price & Analysis

70 Followers

TOMDF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume200.00K
Average Volume (3M)N/A
Market Cap
$1.41K
Enterprise Value$36.26M
Total Cash (Recent Filing)$57.00K
Total Debt (Recent Filing)$35.74M
Price to Earnings (P/E)-0.5
Beta1.26
Nov 15, 2022
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,410,000,000
10 Day Avg. Volume92,233
30 Day Avg. VolumeN/A
Standard Deviation0.48
R-Squared0.03
Alpha0.00096
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.37
Enterprise Value/Gross Profit8.27
Enterprise Value/Ebitda-4.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

12.67%0.00%0.00%87.33%
12.67%
Insiders
0.00% Other Institutional Investors
87.33% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

TOMDF FAQ

What was Todos Medical Ltd.’s price range in the past 12 months?
Currently, no data Available
What is Todos Medical Ltd.’s market cap?
Currently, no data Available
When is Todos Medical Ltd.’s upcoming earnings report date?
Todos Medical Ltd.’s upcoming earnings report date is Nov 15, 2022 which is 500 days ago.
    How were Todos Medical Ltd.’s earnings last quarter?
    Todos Medical Ltd. released its earnings results on Aug 23, 2022. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
      Is Todos Medical Ltd. overvalued?
      According to Wall Street analysts Todos Medical Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Todos Medical Ltd. pay dividends?
        Todos Medical Ltd. does not currently pay dividends.
        What is Todos Medical Ltd.’s EPS estimate?
        Todos Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Todos Medical Ltd. have?
        Todos Medical Ltd. has 1,408,127,200 shares outstanding.
          What happened to Todos Medical Ltd.’s price movement after its last earnings report?
          Todos Medical Ltd. reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of Todos Medical Ltd.?
            Currently, no hedge funds are holding shares in TOMDF
            ---

            Todos Medical Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Company Description

            Todos Medical Ltd.

            Todos Medical Ltd. operates as a cancer in vitro-diagnostic firm. It develops a series of patient-friendly blood tests for the screening of a variety of cancers. The company focuses on the goal of creating a new methodology for cancer detection tests that make cancer detection more accurate, accessible, and affordable to the general public. It has a two cancer screening tests, TM-B1 and TM-B2. Todos Medical was founded by Rami Zigdon and Udi Zelig in April 2010 and is headquartered in Rehovot, Israel.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Aethlon Medical
            Verastem
            Onconova Therapeutics
            Cocrystal Pharma
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis